Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Emergency Drugs |Emergency Drug Antidotes |Emergency Cardiac Drugs |Emergency Endocrine Drugs |Emergency Gastrointestinal Drugs |Emergency Haematology Drugs |Emergency Neuropsychiatric drugs |Emergency Pain drugs |Emergency Respiratory drugs |Emergency Obstetric and Gynaecology Drugs |Emergency Paediatric Drugs
DRUG (UK Name) | MOA | DOSE IV | DOSE PO | INDICATION | CONTRAINDICATION / CAUTION |
---|---|---|---|---|---|
Adenosine | Acts on A1 receptors in the AV node to transiently block conduction | 6 mg IV rapid push; if no effect, 12 mg IV after 1–2 min; may repeat 12 mg once | N/A | Stable SVT, stable narrow complex tachycardia | Avoid in 2nd/3rd degree AV block without pacing; can cause transient bradycardia/asystole; check BNF for pregnancy |
Amiodarone | Class III antiarrhythmic (K+ channel block), also Class I, II, IV effects |
VF/VT arrest: 300 mg IV push, then 150 mg if needed
Stable wide complex tachy: 150 mg IV over 10 min, then infusion (1 mg/min x6h, then 0.5 mg/min) |
N/A | VF/VT, wide complex tachyarrhythmias | Hypotension, potential proarrhythmia; long half-life; check BNF for pregnancy advice |
Atropine | Anticholinergic, reduces vagal influence on SA/AV node |
Organophosphate poisoning: 1–6 mg IV every 3–5 min until secretions stop
Paediatric bradycardia: 0.02 mg/kg IV once (max single 0.5 mg, max total 1 mg) Adult bradycardia: 0.5 mg IV every 3–5 min (max 3 mg) |
N/A | Bradycardia, organophosphate/carbamate poisoning | Hyperthermia, tachyarrhythmias; consult BNF for pregnancy |
Calcium Gluconate/Chloride | Increases serum Ca²⁺, stabilises cardiac membrane | Typically 10% solution: 1 g (in 10 mL) IV | N/A | Hyperkalaemia, hypocalcaemia with arrhythmias | CaCl is more irritant and 3x more potent than Ca gluconate; central line preferred for CaCl; check BNF for pregnancy |
Diltiazem | Non-dihydropyridine Ca²⁺ channel blocker; slows AV conduction | 0.25 mg/kg IV bolus, may repeat 0.35 mg/kg IV after 15 min; infusion 5–15 mg/h | N/A | Stable AF with RVR, stable SVT | May cause hypotension, bradycardia; use caution in heart failure; check BNF for pregnancy |
Dobutamine | Beta-1 agonist (with some Beta-2) | 2–20 micrograms/kg/min IV infusion | N/A | Acute heart failure, cardiogenic shock | Tachycardia, arrhythmias; ensure adequate volume status; check BNF for pregnancy |
Dopamine | Alpha, Beta-1, and dopaminergic receptor agonist (dose-dependent) |
<5 micrograms/kg/min (renal/dopaminergic - not typically recommended)
5–10 micrograms/kg/min (beta effects) 10–20 micrograms/kg/min (alpha effects) |
N/A | Hypotension, heart failure | Arrhythmias, tissue necrosis with extravasation (use central line); check BNF for pregnancy |
Adrenaline (Epinephrine) | Alpha and Beta agonist |
Cardiac arrest: 1 mg of 1:10,000 IV every 3–5 min
Anaphylaxis: 0.5 mg of 1:1,000 IM (adults) Hypotension/shock: 1–10 micrograms/min IV infusion (titrate) |
N/A | Cardiac arrest, anaphylaxis, severe hypotension, severe asthma | Risk of arrhythmias, extravasation injury; verify doses carefully; consult BNF for pregnancy |
Esmolol | Short-acting selective Beta-1 blocker | 500 micrograms/kg IV loading, then 50–300 micrograms/kg/min infusion | N/A | Aortic dissection (rate control), arrhythmias | Can precipitate heart failure, hypotension, bronchospasm; check BNF for pregnancy |
Furosemide (Frusemide) | Loop diuretic inhibiting Na⁺/K⁺/2Cl⁻ in ascending loop | 20–40 mg IV initially, reassess; can go up to 200 mg single dose if needed | N/A | Acute pulmonary oedema, fluid overload states | Hypovolaemia, electrolyte depletion, ototoxicity; check BNF for pregnancy |
Labetalol | Combined alpha and beta blocker | Bolus: 20–80 mg IV every 10 min PRN; Infusion: 1–8 mg/min titrated | N/A | Hypertensive emergencies | Can precipitate heart failure, bradycardia, bronchospasm; check BNF for pregnancy |
Magnesium Sulfate | Essential electrolyte, membrane stabiliser, reduces neuromuscular excitability |
Eclampsia: 2–4 g IV load over ~5 min
Torsades: 2 g IV push Asthma: 2 g IV over 15 min |
N/A | Eclampsia, torsades de pointes, severe asthma | Hypotension if given rapidly, respiratory depression if overdosed; safe in pregnancy (commonly used for eclampsia) |
Glyceryl Trinitrate (GTN, Nitroglycerin) | Venodilator, increases cGMP | 5–200 micrograms/min IV, increase by 10 micrograms every 3–5 min until desired effect | N/A | Angina, CHF, acute pulmonary oedema | Hypotension, headache, rare methemoglobinaemia; check BNF for pregnancy |
Sodium Nitroprusside | Direct vasodilator via NO release | Start at 0.3 micrograms/kg/min IV, titrate; max 10 micrograms/kg/min. If no control after 10 min at max, stop. | N/A | Hypertensive emergencies | Cyanide toxicity (prolonged infusion), methemoglobinaemia, hypotension; check BNF for pregnancy |
Norepinephrine (Noradrenaline) | Potent alpha-1 > beta-1 agonist | 1–30 micrograms/min IV infusion (titrate to BP) | N/A | Refractory hypotension (septic shock, other shock states) | Arrhythmias, extravasation injury (use central line); check BNF for pregnancy |